Cargando…
The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer
PURPOSE: The CRP/albumin (Alb) ratio, a recently reported predictor, has shown value for prognosis in various human cancers. This study aimed to determine the prognostic value of baseline CRP/Alb and to explore the relevance between postchemotherapy CRP/Alb and the efficacy of chemotherapy in advanc...
Autores principales: | Fan, Zhiyao, Fan, Kun, Gong, Yitao, Huang, Qiuyi, Yang, Chao, Cheng, He, Jin, Kaizhou, Ni, Quanxing, Yu, Xianjun, Luo, Guopei, Liu, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778322/ https://www.ncbi.nlm.nih.gov/pubmed/31632137 http://dx.doi.org/10.2147/CMAR.S211363 |
Ejemplares similares
-
Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms
por: Deng, Shengming, et al.
Publicado: (2021) -
Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients
por: Gong, Yitao, et al.
Publicado: (2020) -
Prognosis of distal pancreatic cancers controlled by stage
por: Luo, Guopei, et al.
Publicado: (2020) -
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2020) -
Lewis antigen-negative pancreatic cancer: An aggressive subgroup
por: Liu, Chen, et al.
Publicado: (2020)